ID

27400

Description

Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00735904

Link

https://clinicaltrials.gov/show/NCT00735904

Keywords

  1. 11/13/17 11/13/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 13, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Carcinoma, Non-Small-Cell Lung (NSCLC) NCT00735904

Eligibility Carcinoma, Non-Small-Cell Lung (NSCLC) NCT00735904

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically- or cytologically-confirmed diagnosis of squamous nsclc stage iiib with malignant effusion (fluid cytology demonstrating malignant cells required), stage iv, or recurrent disease after definitive local therapy
Description

Non-Small Cell Lung Carcinoma Squamous TNM clinical staging | Malignant Effusion | Local Therapy | Recurrent disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1182670
UMLS CUI [1,3]
C3258246
UMLS CUI [2]
C0080032
UMLS CUI [3]
C1517925
UMLS CUI [4]
C0277556
candidate for primary treatment with cisplatin and gemcitabine
Description

First line treatment | Cisplatin | gemcitabine

Data type

boolean

Alias
UMLS CUI [1]
C1708063
UMLS CUI [2]
C0008838
UMLS CUI [3]
C0045093
presence of measurable disease by recist
Description

Measurable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
adequate organ function as defined by the following criteria: ecog performance status of 0 or 1
Description

Organ function | ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior systemic treatment for stage iiib (with malignant effusion) or stage iv nsclc.
Description

Systemic therapy Non-Small Cell Lung Carcinoma TNM clinical staging | Malignant Effusion | Non-Small Cell Lung Carcinoma TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0007131
UMLS CUI [1,3]
C3258246
UMLS CUI [2]
C0080032
UMLS CUI [3,1]
C0007131
UMLS CUI [3,2]
C3258246
one or more lung lesions with cavitation, or any lesion invading or abutting a major blood vessel as assessed by ct or mri.
Description

Lesion of lung Quantity | Cavitation | Lesion Blood Vessel Major CT | Lesion Blood Vessel Major MRI

Data type

boolean

Alias
UMLS CUI [1,1]
C0577916
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C0578537
UMLS CUI [3,1]
C0221198
UMLS CUI [3,2]
C0005847
UMLS CUI [3,3]
C0205164
UMLS CUI [3,4]
C0040405
UMLS CUI [4,1]
C0221198
UMLS CUI [4,2]
C0005847
UMLS CUI [4,3]
C0205164
UMLS CUI [4,4]
C0024485
history of hemoptysis > ½ tsp (2.5 ml) of blood per day for a day or more within 1 week of study treatment, or grade 3 or 4 hemoptysis within 4 weeks of study treatment
Description

Hemoptysis Amount Duration | Hemoptysis Grade

Data type

boolean

Alias
UMLS CUI [1,1]
C0019079
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0449238
UMLS CUI [2,1]
C0019079
UMLS CUI [2,2]
C0441800
nci ctcae grade 3 hemorrhage from any cause within 4 weeks of study treatment
Description

Hemorrhage CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0019080
UMLS CUI [1,2]
C1516728
preexisting uncontrolled hypertension as documented by 2 baseline blood pressure readings taken at least 1 hour apart.
Description

Uncontrolled hypertension Pre-existing | Blood pressure finding Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C2347662
UMLS CUI [2,1]
C1271104
UMLS CUI [2,2]
C1265611
untreated brain metastases.
Description

Metastatic malignant neoplasm to brain Untreated

Data type

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0332155
need for therapeutic anticoagulation, regular use of aspirin (> 325 mg/day), nsaid or other medications known to inhibit platelet function.
Description

Anticoagulation Therapy Patient need for | Aspirin Regular U/day | NSAID Regular | Platelet Inhibitors Regular

Data type

boolean

Alias
UMLS CUI [1,1]
C0003281
UMLS CUI [1,2]
C0686904
UMLS CUI [2,1]
C0004057
UMLS CUI [2,2]
C0205272
UMLS CUI [2,3]
C0456683
UMLS CUI [3,1]
C0003211
UMLS CUI [3,2]
C0205272
UMLS CUI [4,1]
C0032188
UMLS CUI [4,2]
C0205272

Similar models

Eligibility Carcinoma, Non-Small-Cell Lung (NSCLC) NCT00735904

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Squamous TNM clinical staging | Malignant Effusion | Local Therapy | Recurrent disease
Item
histologically- or cytologically-confirmed diagnosis of squamous nsclc stage iiib with malignant effusion (fluid cytology demonstrating malignant cells required), stage iv, or recurrent disease after definitive local therapy
boolean
C0007131 (UMLS CUI [1,1])
C1182670 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0080032 (UMLS CUI [2])
C1517925 (UMLS CUI [3])
C0277556 (UMLS CUI [4])
First line treatment | Cisplatin | gemcitabine
Item
candidate for primary treatment with cisplatin and gemcitabine
boolean
C1708063 (UMLS CUI [1])
C0008838 (UMLS CUI [2])
C0045093 (UMLS CUI [3])
Measurable Disease
Item
presence of measurable disease by recist
boolean
C1513041 (UMLS CUI [1])
Organ function | ECOG performance status
Item
adequate organ function as defined by the following criteria: ecog performance status of 0 or 1
boolean
C0678852 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Systemic therapy Non-Small Cell Lung Carcinoma TNM clinical staging | Malignant Effusion | Non-Small Cell Lung Carcinoma TNM clinical staging
Item
prior systemic treatment for stage iiib (with malignant effusion) or stage iv nsclc.
boolean
C1515119 (UMLS CUI [1,1])
C0007131 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0080032 (UMLS CUI [2])
C0007131 (UMLS CUI [3,1])
C3258246 (UMLS CUI [3,2])
Lesion of lung Quantity | Cavitation | Lesion Blood Vessel Major CT | Lesion Blood Vessel Major MRI
Item
one or more lung lesions with cavitation, or any lesion invading or abutting a major blood vessel as assessed by ct or mri.
boolean
C0577916 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0578537 (UMLS CUI [2])
C0221198 (UMLS CUI [3,1])
C0005847 (UMLS CUI [3,2])
C0205164 (UMLS CUI [3,3])
C0040405 (UMLS CUI [3,4])
C0221198 (UMLS CUI [4,1])
C0005847 (UMLS CUI [4,2])
C0205164 (UMLS CUI [4,3])
C0024485 (UMLS CUI [4,4])
Hemoptysis Amount Duration | Hemoptysis Grade
Item
history of hemoptysis > ½ tsp (2.5 ml) of blood per day for a day or more within 1 week of study treatment, or grade 3 or 4 hemoptysis within 4 weeks of study treatment
boolean
C0019079 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0019079 (UMLS CUI [2,1])
C0441800 (UMLS CUI [2,2])
Hemorrhage CTCAE Grades
Item
nci ctcae grade 3 hemorrhage from any cause within 4 weeks of study treatment
boolean
C0019080 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Uncontrolled hypertension Pre-existing | Blood pressure finding Quantity
Item
preexisting uncontrolled hypertension as documented by 2 baseline blood pressure readings taken at least 1 hour apart.
boolean
C1868885 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C1271104 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Metastatic malignant neoplasm to brain Untreated
Item
untreated brain metastases.
boolean
C0220650 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Anticoagulation Therapy Patient need for | Aspirin Regular U/day | NSAID Regular | Platelet Inhibitors Regular
Item
need for therapeutic anticoagulation, regular use of aspirin (> 325 mg/day), nsaid or other medications known to inhibit platelet function.
boolean
C0003281 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0205272 (UMLS CUI [2,2])
C0456683 (UMLS CUI [2,3])
C0003211 (UMLS CUI [3,1])
C0205272 (UMLS CUI [3,2])
C0032188 (UMLS CUI [4,1])
C0205272 (UMLS CUI [4,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial